Akso Health Group (AHG) Financial Ratios
11 years of historical data (2015–2025) · Financial Services · Financial - Credit Services
EV/EBITDA
N/A
—
5yr avg: N/A
30Y Low5.3·High5.3
P/FCF
↑
571.47
↑+389% vs avg
5yr avg: 116.78
30Y Low0.9·High20.5
P/B Ratio
↑
2.93
↑+301% vs avg
5yr avg: 0.73
30Y Low0.2·High3.8
ROE
↑
-80.0%
↑-23% vs avg
5yr avg: -65.3%
30Y Low-114%·High80%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
AHG Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Akso Health Group currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 571.5x P/FCF, 389% above the 5-year average of 116.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $584M | $336M | $28M | $3M | $11M | $10M | $20M | $177M | $539M | — | — |
| Enterprise Value | $408M | $160M | $-57535663 | $-5218656 | $-7236150 | $4M | $35M | $139M | $406M | — | — |
| P/E Ratio → | -4.27 | — | — | — | — | — | — | 32.32 | 8.24 | — | — |
| P/S Ratio | 39.55 | 22.76 | 11.45 | 0.21 | 1.87 | 5.44 | 2.96 | 47.83 | 5.03 | — | — |
| P/B Ratio | 2.93 | 1.69 | 0.20 | 0.31 | 0.91 | 0.55 | 0.43 | 1.40 | 3.85 | — | — |
| P/FCF | 571.47 | 328.95 | 20.45 | — | — | 0.95 | — | — | 6.18 | — | — |
| P/OCF | 496.49 | 285.78 | 20.45 | — | — | 0.95 | — | — | 6.14 | — | — |
P/E links to full P/E history page with 30-year chart
AHG EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.85 | -23.83 | -0.40 | -1.21 | 2.52 | 5.00 | 37.71 | 3.79 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | 5.34 | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | 5.31 | — | — |
| EV / FCF | — | 156.71 | -42.58 | — | — | 0.44 | — | — | 4.66 | — | — |
AHG Profitability
Margins and return-on-capital ratios measuring operating efficiency
Akso Health Group earns an operating margin of -1125.4%, below the Financial Services sector average of 21.6%. Operating margins have compressed from -108.2% to -1125.4% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -80.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1.9% | -1.9% | 5.1% | 9.6% | 10.1% | 69.0% | 100.0% | 100.0% | 92.1% | 77.5% | 80.2% |
| Operating Margin | -1125.4% | -1125.4% | -357.8% | -108.2% | -54.3% | -1547.1% | -695.7% | -194.6% | 70.7% | 43.3% | 34.8% |
| Net Profit Margin | -913.4% | -913.4% | -391.8% | -10.3% | -280.8% | -1984.5% | -1029.7% | 149.7% | 61.1% | 37.4% | 29.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -80.0% | -80.0% | -12.8% | -12.9% | -114.0% | -106.5% | -81.6% | 4.2% | 80.1% | 45.7% | 40.8% |
| ROA | -75.6% | -75.6% | -11.6% | -3.3% | -35.7% | -62.1% | -56.1% | 3.3% | 68.1% | 33.8% | 23.8% |
| ROIC | -73.9% | -73.9% | -8.8% | -101.3% | -12.4% | -42.4% | -33.5% | -3.8% | 69.6% | 39.6% | 35.8% |
| ROCE | -98.0% | -98.0% | -11.7% | -135.1% | -22.1% | -63.6% | -44.8% | -5.0% | 92.8% | 52.8% | 47.7% |
AHG Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $176M exceeds total debt of $81737, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | — | — | — | 0.58 | 0.43 | 0.16 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.88 | -0.62 | -0.90 | -1.50 | -0.30 | 0.29 | -0.30 | -0.95 | -0.82 | -0.56 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | -1.74 | -1.92 | -1.86 |
| Debt / FCF | — | -172.24 | -63.03 | — | — | -0.51 | — | — | -1.52 | -2.43 | -1.13 |
| Interest Coverage | — | — | — | — | -4.05 | -12.60 | -19.25 | — | — | — | — |
Net cash position: cash ($176M) exceeds total debt ($81737)
AHG Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Akso Health Group's current ratio of 14.20x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.76x to 14.20x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.20 | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 | 4.21 | 3.68 | 6.84 | 5.65 | 1.15 |
| Quick Ratio | 14.20 | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 | 4.21 | 3.68 | 6.84 | 5.65 | 1.15 |
| Cash Ratio | 12.76 | 12.76 | 23.70 | 0.68 | 0.36 | 1.05 | 0.54 | 2.16 | 5.56 | 3.94 | 0.93 |
| Asset Turnover | — | 0.07 | 0.02 | 0.64 | 0.10 | 0.06 | 0.09 | 0.02 | 0.65 | 0.81 | 0.53 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
AHG Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Akso Health Group does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 11.1% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 353.3% | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | 3.1% | 12.1% | — | — |
| FCF Yield | 0.2% | 0.3% | 4.9% | — | — | 105.3% | — | — | 16.2% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 0.7% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 11.8% | 0.0% | — | — |
| Shares Outstanding | — | $285M | $24M | $8M | $7M | $5M | $5M | $6M | $5M | $5M | $5M |
Peer Comparison
Compare AHG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AHGYou | $584M | -4.3 | — | 571.5 | -1.9% | -1125.4% | -80.0% | -73.9% | — |
 JFIN | $534M | 1.7 | 2.5 | 5.3 | 64.9% | 21.5% | 38.4% | 39.9% | 0.0 |
 QFIN | $4B | 2.1 | 3.0 | 2.8 | 61.8% | 43.9% | 27.1% | 23.1% | 0.2 |
 LX | $147M | 2.2 | 1.6 | 1.2 | 35.4% | 16.1% | 10.8% | 11.0% | 2.2 |
 FINV | $3B | 3.8 | 5.8 | 6.9 | 79.3% | 19.4% | 16.2% | 12.9% | 0.0 |
 HCM | $2B | 60.5 | — | — | 44.6% | -6.9% | 5.0% | -5.2% | — |
 BTBT | $589M | 9.2 | 8.5 | — | 61.9% | 16.8% | 9.2% | 6.5% | 0.2 |
 NHTC | $36M | -41.7 | — | — | 73.5% | -4.5% | -3.1% | -6.5% | — |
 CLOV | $1B | -16.6 | — | — | 18.5% | -4.4% | -26.3% | -34.0% | — |
 TDOC | $1B | -6.1 | 15.1 | 4.4 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 ACMR | $4B | 43.2 | 27.5 | — | 44.4% | 12.1% | 6.2% | 7.0% | 2.4 |
| Financial Services Median | — | 13.1 | 11.5 | 10.6 | 63.6% | 21.6% | 9.4% | 5.7% | 4.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
See AHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHG vs JFIN
Side-by-side business, growth, and profitability comparison vs Jiayin Group Inc..
Start ComparisonAHG — Frequently Asked Questions
Quick answers to the most common questions about buying AHG stock.
What is Akso Health Group's P/E ratio?
Akso Health Group's current P/E ratio is -4.3x. The historical average is 20.3x.
What is Akso Health Group's ROE?
Akso Health Group's return on equity (ROE) is -80.0%. The historical average is -22.5%.
Is AHG stock overvalued?
Based on historical data, Akso Health Group is trading at a P/E of -4.3x. Compare with industry peers and growth rates for a complete picture.
What are Akso Health Group's profit margins?
Akso Health Group has -1.9% gross margin and -1125.4% operating margin.